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 Patient: Male, 52
 Final Diagnosis: Cryptococcal ventriculoperitoneal shunt infection
 Symptoms: Confusion • fever • Lethargy
 Medication: Amphotericin B • Flucytosine
 Clinical Procedure: Ventriculoperitoneal shunt removal
 Specialty: Infectious disease
 Objective: Rare disease
 Background: Ventriculoperitoneal shunting is an effective treatment for hydrocephalus. Ventriculoperitoneal shunt (VPS) in-
fection is a common complication. Cryptococcus neoformans as an implicated organism is rare. In this report, 
we describe a patient with cryptococcal VPS infection.
 Case Report: A 52-year-old male with normal pressure hydrocephalus, status post implantation of VPS one year prior to 
the presentation; who was admitted with a fever, lethargy and confusion for three days. He was treated em-
pirically with intravenous cefepime and vancomycin for VPS infection. The CSF analysis from both the lumbar 
puncture and the VPS was significant for a low white blood count, low glucose and high protein. Other work-
up including India ink and cryptococcal antigen was unrevealing. He remained febrile despite antibiotic treat-
ment for 5 days. The CSF from the shunt was sent for analysis again and it demonstrated similar results from 
the prior study, but the culture was now positive for Cryptococcus neoformans. The patient was started on oral 
flucytosine and intravenous liposomal amphotericin B. The VPS was removed and an externalized ventricular 
catheter was placed. The patient showed rapid resolution of the symptoms.
 Conclusions: To date, there was a total of nine reported cases of cryptococcal VPS infection upon review of the literature. 
Our presenting case and the literature review highlight the difficulties in making an accurate diagnosis of cryp-
tococcal shunt infection. There were case reports of false negative cryptococcal antigen tests with culture prov-
en cryptococcal meningitis. The CSF culture from the shunt remains a mainstay for identifying cryptococcal 
shunt infection. Cryptococcal shunt infections are rare and early diagnosis and treatment is essential for pa-
tient management which involves shunt replacement with concomitant administration of intravenous antifun-
gal medication. High clinical suspicion is crucial and shunt culture preferably from the valve is recommended.
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Background
Ventriculoperitoneal shunting is a commonly used method to 
drain the excess cerebrospinal fluid from the cerebral ventricles 
into the peritoneal space in patients with hydrocephalus [1]. 
While VPS is effective in reducing morbidity and mortality, it 
also has complications. VPS infection is a common complica-
tion, with an incidence of 2% to 12% [2–4]. Bacteria such as 
coagulase-negative staphylococci are the most commonly im-
plicated organism [4–7]. Cryptococcus neoformans as a patho-
gen of VPS infections is rare and the diagnosis using CSF from 
the shunt can be particularly difficult [8–10]. In immunocom-
petent patients, cryptococcal antigen tests may be negative, 
which makes the diagnosis more challenging [11,12]. We present 
the case of an immunocompetent patient who was diagnosed 
with culture-proven Cryptococcus neoformans VPS infection.
Case Report
The patient was a 52-year-old man with a past medical histo-
ry significant for normal-pressure hydrocephalus, status post-
implantation of VPS 1 year prior to the presentation, who was 
admitted with fever, lethargy, and confusion for 3 days.
On physical examination, he was febrile, with a temperature 
of 101.7°F. The patient was alert and oriented to person and 
place only. There was no neck rigidity or focal neurological 
deficits, and Kernig and Brudzinski signs were negative. The 
physical exam was otherwise unremarkable.
A clinical diagnosis of VPS infection was made, and the patient 
was started empirically on intravenous cefepime 2 g every 12 
h and vancomycin 15 mg/kg every 8 h. The serum white blood 
cell count was 8.3×10/dl and C-reactive protein was 14.4 mg/dl. 
A computed tomography (CT) scan of the head showed ventric-
ulomegaly with possible shunt malfunction. CSF obtained from 
a lumbar puncture and the VPS were sent for culture. The CSF 
analysis from the shunt was significant for a low white blood 
cell count (WBC), low glucose, and high protein (Table 1). The 
opening pressure from the lumbar puncture was within nor-
mal limits. India ink microscopy was negative for capsulated 
organism. The cultures from both sources remained negative 
for 7 days. In addition, latex agglutination for cryptococcal an-
tigen was negative.
The patient underwent a shunt revision with externalization 
of the peritoneal catheter on day 2. He remained febrile de-
spite 5-day antibiotic treatment. Further investigation, includ-
ing CSF acid-fast bacilli smear, Lyme DNA polymerase chain 
reaction, and Venereal Disease Research Laboratory (VDRL) 
were all negative. The CSF from the shunt was sent for anal-
ysis again and it demonstrated similar results from the prior 
study, but the culture was now positive for Cryptococcus neo-
formans. Human immunodeficiency virus (HIV), hepatitis B, 
and hepatitis C screening were non-reactive. The patient de-
nied any malignancy, organ translation, or long-term gluco-
corticoid therapy.
The patient was started on oral flucytosine 25 mg/kg every 6 
h and intravenous liposomal amphotericin B 15 mg/kg daily. 
A repeat culture revealed persistent Cryptococcus neoformans. 
The VPS was removed and an externalized ventricular catheter 
Sex
 Male 9
 Female 1
Age, mean ± age 45±14
Co-morbidities, n (%)
 Cirrhosis 1 (10)
 Small cell cancer 1 (10)
 Sarcoidosis 1 (10)
Duration from VPS placement to infection
  Duration from VPS placement to 
infection >1 year, n (%)
1 (11.1)
  Duration from VPS placement to 
infection £1 year, n (%)
8 (88.9)
1 case NR
VPS cerebrospinal fluid analysis
 WBC >10 cells/uL, n (%)
4/8 (50)
2 cases NR
 Glucose <50 mg/dl, n (%)
6/9 (66.7)
1 case NR
 Total protein >40 mg/dl, n (%)
9/9 (100)
1 case NR
Cryptococcal antigen test positive, n (%)
4/6 (66.7)
4 cases NR
Cryptococcal Culture, n (%) 10/10 (100)
Treatment
  Amphotericin B and flucytosine only, 
n (%)
9 (90)
  Removal of shunt, amphotericin B and 
flucytosine, n (%)
8 (80)
Mortality attributed to Cryptococcal VPS 
infection, n (%)
4 (40)
Table 1.  Summary of the present case and available data on 
9 cases of Cryptococcal VPS infection in the English 
literature.
VPS – ventriculoperiteneal shunt; WBC – white blood count; 
NR – not reported.
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was placed. Multiple CSF cultures after shunt removal were 
negative. The patient continued to improve clinically and re-
mained afebrile. He completed a 2-week induction phase with 
flucytosine and amphotericin B, followed by an 8-week course 
of per oral fluconazole 800 mg daily. A new VPS was placed 3 
weeks after the original VPS was removed.
Discussion
In this paper, we presented an immunocompetent patient with 
culture-proven cryptococcal VPS infection. Cryptococcal infection 
is a rare etiology of VPS infection. Our review of the literature 
showed that there have been a total of 9 reported cases [8,9].
The CSF profile of cryptococcal meningitis in HIV-negative pa-
tients has a median WBC, protein, and glucose of 73 leuco-
cytes/mm3, 100 mg/dl, and 42 mg/dl, respectively [13]. The 
interpretation of CSF parameters of device-related infection 
is challenging and may be different from meningitis in HIV-
negative patients. There is no single CSF parameter proposed 
to consistently predict cryptococcal VPS infection [14].
Table shows that 50% of patients had an elevated CSF WBC 
(>10 cells/uL), 66.7% had low CSF glucose (<50 mg/dl), and all 
the patients had high protein (>40 mg/dl). The CSF cryptococ-
cal antigen tests were negative in 2 patients. Although cryp-
tococcal antigen agglutination test of CSF samples has a sen-
sitivity of 100% and a specificity of 95% to 100%, there were 
case reports of false-negative cryptococcal antigen test results 
with culture-proven cryptococcal meningitis [6,15,16]. It was 
thought that this could be a result of low cryptococcal antigen 
concentrations in the CSF and also is dependent on the type 
of test kit used [6,11,12]. Other reported causes of negative 
cryptococcal antigen test results include prozone phenome-
non [17] and isolation of small colony variant of Cryptococcus 
neoformans [18].
Table 1 also shows that CSF cultures from the shunt were pos-
itive for Cryptococcus neoformans in all the patients. The pre-
sented case is unique because the CSF culture from the shunt 
was initially negative but a second sample grew Cryptococcus 
neoformans. According to some studies, there had been re-
ports that revealed failures to isolate causative agents in the 
cultures [11,19]. Nevertheless, the CSF culture from the shunt 
remains a mainstay for identifying cryptococcal shunt infec-
tion [7,15]. Desai et al. suggests holding the shunt culture for 
10 days to allow adequate pathogen recovery time [20].
We would like to acknowledge the limitations of our case re-
port. Our patient may have been infected during the shunt 
revision, which caused the repeat culture to be positive. 
However, the patient’s clinical presentation did not improve 
despite broad-spectrum antibiotics and shunt revision. The 
repeated CSF analysis from the shunt showed a similar result 
after the shunt revision. Therefore, nosocomial cryptococcal 
infection was less consistent. The latency time from contam-
ination to symptoms is highly variable, ranging from 30 days 
to more than a year [20]. Table 1 shows that 88.9% of report-
ed cryptococcal VPS infections occurred less than a year af-
ter the VPS placement.
Conclusions
Cryptococcal shunt infections are rare. Early diagnosis and treat-
ment are essential for patient management, which involves 
shunt replacement with concomitant administration of intra-
venous antifungal medication. Our presented case and the lit-
erature review highlight the difficulties in making an accurate 
diagnosis of cryptococcal shunt infection. High clinical suspi-
cion is crucial and shunt culture, preferably from the valve and 
reservoir, is recommended [21].
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